疏气定痛汤治疗气滞血瘀型慢性盆腔炎临床观察  被引量:7

Clinical Observation on 35 Patients with Qi Stagnancy and Blood Stasis Syndrome in Chronic Pelvic Inflammatory Disease Treated by Shuqi Dingtong Formula

在线阅读下载全文

作  者:李蕾[1] 

机构地区:[1]首都医科大学潞河教学医院,北京101149

出  处:《中华中医药学刊》2012年第10期2361-2362,共2页Chinese Archives of Traditional Chinese Medicine

基  金:首都医科大学潞河教学医院医学发展基金资助项目

摘  要:目的:观察疏气定痛汤治疗气滞血瘀型慢性盆腔炎的疗效。方法:将气滞血瘀型慢性盆腔炎患者68例随机分成两组,治疗组35例口服疏气定痛汤加减方,对照组33例口服甲硝唑片和左氧氟沙星片,两组均治疗2个疗程,每疗程20天。治疗前、治疗结束时分别观察两组的症状积分;治疗结束时观察两组的疗效;治疗结束后3个月随访患者,观察复发率。结果:治疗组和对照组的总有效率分别是91.4%、66.7%,两组总有效率比较差异有统计学意义(P<0.05)。治疗结束时,治疗组和对照组的症状积分分别是5.6±2.8、9.1±3.7,两组症状积分比较差异有统计学意义(P<0.01)。治疗组和对照组的复发率分别是18.75%、45.45%,两组复发率比较差异有统计学意义(P<0.05)。结论:疏气定痛汤治疗气滞血瘀型慢性盆腔炎的疗效优于抗生素,并且复发率低。Objective:To evaluate effect of Shuqi Dingtong Formula on Qi stagnancy and blood stasis syndrome in Chronic Pelvic Inflammatory Disease (CPID). Methods:Totally 68 patients were randomized into treatment group and control group. The treatment group was treated with Shuqi Dingtong Formula. The control group was treated with Metronidazole and Levofloxacin. The course of treatment was 40 days. Symptom integral was observed for all patients at the time of pre -treatment, post- treatment and follow- up for comparing the curative effect. Recurrence rate was evaluated 3 months after treatment. Results:The total effective rate of the treatment group was 91.4% while that of the control group was 66. 7% , the difference was significant (P 〈 0.05 ). After treatment, the symptom integral of the treatment group was fewer than that of the control group ( P 〈 O. 01 ). The recurrence rate of the treatment group was 18.75 % while that of the control group was 45.45%, the difference was significant( P 〈 O. 05 ). Conclusion:Shuqi Dingtong Formula is more effective than antibiotic in treating CPID. At the same time, the recurrence rate is lower.

关 键 词:疏气定痛汤 慢性盆腔炎:气滞血瘀证 

分 类 号:R711.33[医药卫生—妇产科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象